Raymond James Financial Services Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,658
| Closed | -$308K | – | 3448 |
|
|
2023
Q3 | $308K | Sell |
2,658
-57
| -2% | -$6.59K | ﹤0.01% | 2627 |
|
|
2023
Q2 | $279K | Sell |
2,715
-383
| -12% | -$39.4K | ﹤0.01% | 2698 |
|
|
2023
Q1 | $338K | Sell |
3,098
-71,537
| -96% | -$7.81M | ﹤0.01% | 2568 |
|
|
2022
Q4 | $8.49M | Sell |
74,635
-1,831
| -2% | -$208K | 0.02% | 721 |
|
|
2022
Q3 | $4.73M | Buy |
76,466
+415
| +0.5% | +$25.7K | 0.01% | 938 |
|
|
2022
Q2 | $6.07M | Sell |
76,051
-738
| -1% | -$58.9K | 0.01% | 836 |
|
|
2022
Q1 | $8.08M | Sell |
76,789
-13,616
| -15% | -$1.43M | 0.02% | 775 |
|
|
2021
Q4 | $9.74M | Buy |
90,405
+6,971
| +8% | +$751K | 0.02% | 696 |
|
|
2021
Q3 | $9.14M | Sell |
83,434
-1,480
| -2% | -$162K | 0.02% | 705 |
|
|
2021
Q2 | $7.95M | Buy |
84,914
+3,424
| +4% | +$321K | 0.02% | 760 |
|
|
2021
Q1 | $7.5M | Sell |
81,490
-25,622
| -24% | -$2.36M | 0.02% | 732 |
|
|
2020
Q4 | $7.84M | Buy |
107,112
+6,825
| +7% | +$499K | 0.02% | 654 |
|
|
2020
Q3 | $7.79M | Sell |
100,287
-3,158
| -3% | -$245K | 0.02% | 591 |
|
|
2020
Q2 | $5.75M | Buy |
103,445
+1,696
| +2% | +$94.3K | 0.02% | 652 |
|
|
2020
Q1 | $3.01M | Sell |
101,749
-32,861
| -24% | -$973K | 0.01% | 710 |
|
|
2019
Q4 | $4.87M | Sell |
134,610
-3,066
| -2% | -$111K | 0.02% | 736 |
|
|
2019
Q3 | $3.75M | Buy |
137,676
+368
| +0.3% | +$10K | 0.01% | 801 |
|
|
2019
Q2 | $3.3M | Buy |
137,308
+2,825
| +2% | +$68K | 0.01% | 851 |
|
|
2019
Q1 | $3.55M | Buy |
134,483
+41,093
| +44% | +$1.09M | 0.01% | 790 |
|
|
2018
Q4 | $1.83M | Buy |
+93,390
| New | +$1.83M | 0.01% | 955 |
|
|
2015
Q4 | – | Sell |
-11,757
| Closed | -$233K | – | 1648 |
|
|
2015
Q3 | $233K | Buy |
+11,757
| New | +$233K | ﹤0.01% | 1310 |
|